Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Valo Therapeutics Oy
OY
Active
Y-tunnus 2768695-4
Viikinkaari 6, 00790
Helsinki
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2016 · 9 years old
14 employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Valo Therapeutics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
-2M
-4M
-6M
-8M
-4M
2020
-5M
-25%
2021
-6M
-20%
2022
-6M
0%
2023
-5M
+17%
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
−691
−954
−1 516
−1 788
−1 655
EBITDA
−3 911
−5 385
−6 002
−5 522
−5 211
Depreciation & amort.
−24
−31
−36
−42
−48
EBIT
−3 935
−5 416
−6 038
−5 565
−5 259
Net financials
−61
−315
−1 089
−668
2 381
Profit before tax
−3 995
−5 731
−7 133
−6 227
−2 878
Tax
−0
−0
−0
−12 454
−0
Net profit
−3 995
−5 731
−7 133
6 227
−2 878
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
1 345
6 808
873
1 265
2 811
Equity
−4 572
−9 296
−16 424
−22 656
−3 140
Long-term debt
4 337
4 187
3 311
0
4 137
Short-term debt
1 579
11 917
13 987
18 954
1 813
Total debt
5 916
16 104
17 297
18 954
5 950
Financial ratios
5-year trend
EBITDA margin
-521099900.0%
This company
15.8%
Market median
-3298100733% vs market
2020
2024
Equity ratio
-111.7%
This company
38.2%
Market median
-392% vs market
2020
2024
Return on equity
-287788900.0%
This company
18.4%
Market median
-1564070209% vs market
2020
2024
Net profit margin
-287788900.0%
This company
8.1%
Market median
-3552949483% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.90×
This company
0.62×
Market median
-206% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Valo Therapeutics Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
